31 completed, 4 terminated, 2 active not recruiting, 2 recruiting. 15 Phase 2, 14 Not applicable, 3 Early Phase 1, 3 Phase 3, 2 Phase 1.
Follow Lymphoid Interstitial Pneumonia: new trials by email Literature Review of Lymphoid Interstitial Pneumonia trials Research Report on Lymphoid Interstitial Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orofacial Muscle Pressure and Maxillary Transverse Development Orolingual Manometry using IOPI Pro Deluxe Kit - Maxillary Transversal Deficiency (Maxillary Constriction) and Perioral Muscle Pressures (Tongue, Lip, and Cheek) | Not applicable | Recruiting | Yuzuncu Yil University | 40 | 2026-05-01 | 2026-04-27 |
| 3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations Removable of the full arch implant-supported prostheses - Digital Technology, Prosthesis User | Unknown | Implantology Institute | 20 | 2024-03-30 | 2024-06-26 | |
| THIODERM ELATE for Volume Augmentation in Lips THIODERM ELATE, Juvéderm Ultra 3 - Lip; Anomaly | Not applicable | Withdrawn | Croma-Pharma GmbH | 2024-03-01 | 2024-12-11 | |
| Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids Sofwave - Rhytides, Wrinkle | Not applicable | Completed | Sofwave Medical LTD | 60 | 2023-07-01 | 2025-05-15 |
| Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Atezolizumab, Bevacizumab, Biospecimen Collection - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 430 | 2023-03-13 | 2026-11-12 |
| Four Hyaluronic Acid Fillers for Lip Augmentation Cosmetic lip augmentation - Lip | Not applicable | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 143 | 2021-07-05 | 2022-03-22 |
| Facial Scanning for Lip Support Assessment in Full Arch Implant Rehabilitations Facial scanner - Lip, Prosthesis User | Not applicable | Completed | Implantology Institute | 20 | 2021-06-20 | 2021-09-16 |
| Assessment and Augmentation of Lip Appearance in Specific Study Populations Hyaluronic acid filler - Lip Aging, Lip Augmentation | Phase 4 | Completed | Dieter Manstein, MD | 37 | 2021-05-07 | 2023-07-28 |
| T1 Squamous Cell Carcinomas of the Lip Lip, Lip Cancer | Unknown | Maastricht University Medical Center | 300 | 2021-04-01 | 2023-08-16 | |
| Sjogren's Lung Study Sjogren's Syndrome, Interstitial Lung Disease | Terminated | Stanford University | 51 | 2021-04-01 | 2026-11-09 | |
| RHA® 3 Versus Restylane-L® for Lip Augmentation RHA 3, Restylane-L - Lip Augmentation, Lip | Completed | Teoxane SA | 202 | 2020-10-22 | 2025-02-03 | |
| Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Durvalumab, Intensity Modulated Radiotherapy Treatments - Larynx, Lip | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 18 | 2019-10-07 | 2026-10-22 |
| Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Nivolumab, IDO1 Inhibitor BMS-986205, Therapeutic Conventional Surgery - Lip, Oral Cavity Squamous Cell Carcinoma | Phase 2 | Terminated | Thomas Jefferson University | 65 | 2019-04-09 | 2026-10-19 |
| Hyaluronic Acid Application Following Frenectomy Hyaluronic acid - Frenulum; Hypertrophy, Lip | Not applicable | Completed | Gazi University | 40 | 2019-01-02 | 2019-07-30 |
| Objective Assessment for Cleft Lip Nasal Deformity Correction Rhinoplasty - Nose; Anomaly | Not applicable | Completed | Assiut University | 1 | 2018-10-15 | 2020-09-02 |
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma Cetuximab, Ficlatuzumab - Head and Neck Basaloid Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 2 | Completed | University of Arizona | 78 | 2017-12-05 | 2024-09-04 |
| Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Nivolumab, Tadalafil, Therapeutic Conventional Surgery - Lip, Oral Cavity and Pharynx, Larynx | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 50 | 2017-08-10 | 2025-04-29 |
| Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer Communication Intervention, Watch video, Module completion of the Prepare to Care kit - Caregiver, Malignant Head and Neck Neoplasm | Not applicable | Completed | Wake Forest University Health Sciences | 35 | 2017-05-15 | 2023-01-09 |
| Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer Nivolumab, Ipilimumab, Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy - Larynx, Lip, Oral Cavity and Pharynx | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 24 | 2017-05-11 | 2025-04-29 |
| Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer External Beam Radiation Therapy, Metformin Hydrochloride, Placebo - Larynx, Lip | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 9 | 2017-01-05 | 2025-04-30 |
Showing 20 of 43. Sign in to see all of them.
Squamous Cell Carcinoma of Head and Neck (18) · Head and Neck Neoplasms (12) · Laryngeal Diseases (11) · Tongue Neoplasms (8) · Mouth Neoplasms (6) · Carcinoma, Squamous Cell (4) · Salivary Gland Neoplasms (4) · Hypertrophy (3) · Hypopharyngeal Neoplasms (3) · Laryngeal Neoplasms (3) · Neoplasm Metastasis (3) · Oropharyngeal Neoplasms (3) · Carcinoma (2) · Colonic Neoplasms (2)
Neoplasms by Site (26) · Neoplasms (25) · Neoplasms by Histologic Type (20) · Neoplasms, Glandular and Epithelial (20) · Carcinoma (18) · Carcinoma, Squamous Cell (16) · Respiratory Tract Diseases (16) · Mouth Diseases (15) · Otorhinolaryngologic Diseases (15) · Stomatognathic Diseases (15) · Head and Neck Neoplasms (14) · Mouth Neoplasms (8) · Tongue Diseases (8) · Pathological Conditions, Signs and Symptoms (6) · Salivary Gland Diseases (5)
Cisplatin (5) · 1,2-diaminocyclohexaneplatinum II citrate (4) · Cetuximab (4) · Platinum (4) · Carboplatin (3) · Nivolumab (3) · Bevacizumab (2) · Biopsy (2) · Disulfides (2) · Docetaxel (2) · Fluorouracil (2) · Gefitinib (2) · Gemcitabine (2) · Immunoglobulin G (2) · Radiotherapy, Intensity-Modulated (2)
National Cancer Institute (NCI) (8) · University of Chicago (5) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (3) · Implantology Institute (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assiut University (1) · Croma-Pharma GmbH (1) · Dieter Manstein, MD (1) · ECOG-ACRIN Cancer Research Group (1) · Galderma R&D (1) · Gazi University (1) · Institut Bergonié (1) · Kocaeli University (1) · Maastricht University Medical Center (1) · Marmara University (1)
United States (30) · Turkey (Türkiye) (3) · Canada (2) · Netherlands (2) · Portugal (2) · Austria (1) · China (1) · Egypt (1) · France (1) · Germany (1) · Puerto Rico (1) · South Africa (1)
Adam Luginbuhl, MD (3) · Aarti Bhatia (1) · Chandylen Nightingale (1) · Dieter Manstein, MD, PhD (1) · Duarte Marques, DDS PhD (1) · Duarte Marques, DDS, PhD (1) · Eric Winquist (1) · Erin M Bertino (1) · Everett E Vokes, MD (1) · Everett Vokes, MD (1) · Ezra Cohen, M.D. (1) · Ezra Cohen, MD (1) · Francis G. LeVeque, DDS (1) · Greg Wolf (1)
PMID 12788192, PMID 14719730, PMID 16724649, PMID 19216585, PMID 21497773, PMID 23468283, PMID 25372511, PMID 25503576, PMID 26218401, PMID 30636365, PMID 31618129, PMID 34911681, PMID 35575280, PMID 36977289, PMID 37019367, PMID 37536941
U10CA180820 (3), N01CM00032 (1), N01CM00071 (1), N01CM00099 (1), N01CM62201 (1), P30CA006516 (1), P30CA012197 (1), P30CA014599 (1), P30CA015083 (1), P30CA016056 (1), P30CA016058 (1), P30CA023074 (1), P30CA046592 (1), R03CA208560 (1), R21CA119591 (1)